The Motley Fool

Are you aiming for ‘asymmetric’ returns?

Compared to other assets shares are seen as risky. It’s true that shares are more volatile than cash, bonds and property, but for the most part shares have delivered the better returns over the long-term.

However, not every share offers the same risk and opportunities. If you invest in large blue chips then the risks may be lower but the potential rewards are definitely lower. I can’t imagine Commonwealth Bank of Australia (ASX: CBA) or Woolworths Group Ltd (ASX: WOW) delivering compound returns, excluding franking credits, of more than 10% over the next couple of years.

However, if you fill your portfolio with high-risk shares like FBR Ltd (ASX: FBR) and Catapult Group International Ltd (ASX: CAT) there’s a chance one or two may be big performers, but others could also halve in value in more.

I think the best thing to do is to aim for asymmetric returns. That means where the possible returns are much greater and more likely than the downsides.

For me, the best asymmetric returns can come in two forms. Either the shares are very attractively valued or offer excellent long-term growth prospects.

The cheaper the price you can buy your target share at, the bigger margin of safety you give yourself. Investors can do all the analysis they like, but it’s ultimately about achieving the best purchase price that decides returns. Meaning you need the cash and the ‘bravery’ to buy.

Foolish takeaway

Some of the shares offering high potential and lower downsides at the moment in my opinion are: Paragon Care Ltd (ASX: PGC), Challenger Ltd (ASX: CGF) and Citadel Group Ltd (ASX: CGL).

Another share widely seen as a good growth share that’s attractively priced is this hot stock.

The best dividend share to buy this month

You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited and Paragon Care Limited. The Motley Fool Australia owns shares of and has recommended Catapult Group International Ltd and Challenger Limited. The Motley Fool Australia owns shares of Citadel Group Ltd. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more